Neal D. Shore MD, FACSMedical Director, Carolina Urologic Research Center, Myrtle Beach, South Carolina
Neal D. Shore, MD, FACS is the Medical Director for the Carolina Urologic Research Center. He practices with Atlantic Urology Clinics in Myrtle Beach, South Carolina.
Dr. Shore has conducted more than 250 clinical trials, focusing mainly on GU Oncology, and serves on the Executive Boards of: Society of Urologic Oncology Board, Society of Urologic Oncology Clinical Trials Consortium, and the Large Urology Group Practice Association. He has served on the AUA Male Health Committee; he is currently a member of the AUA Data Committee, the Bladder Cancer Advocacy Think Tank and the editorial boards of Urology Times, Current Urology Reports, Chemotherapy Advisor, OncLive, PlosOne and Urology Practice. He has numerous peer reviewed publications and book chapters; he performs peer review for numerous scientific journals.
A graduate of Duke University and Duke University Medical School, Dr. Shore completed a 6 month clinical research fellowship in Pretoria, South Africa, and then completed his General Surgery/Urology training at New York Hospital Cornell Medical Center and at Memorial Sloan-Kettering Cancer Center in New York City. He is a Fellow of the American College of Surgeons.
Recent Contributions to PracticeUpdate:
- OR Assistance for Major Urologic Surgical Procedures: An Increasing Role for Advanced Practice Providers
- Androgen Deprivation Therapy Has Dose-Dependent Effect on Cardiac Events
- Androgen Deprivation Therapy and Cardiac-Specific Mortality in Men With Prostate Cancer
- Influence of Prior Abiraterone on Clinical Activity of Docetaxel in Metastatic Castration-Resistant Prostate Cancer